Near-infrared spectroscopy in carotid artery stenting predicts cerebral hyperperfusion syndrome

S. Matsumoto, I. Nakahara, T. Higashi, Y. Iwamuro, Y. Watanabe, K. Takahashi, M. Ando, M. Takezawa, J. I. Kira

研究成果: ジャーナルへの寄稿記事

37 引用 (Scopus)

抄録

Objective: Cerebral hyperperfusion syndrome (CHS) following carotid artery stenting (CAS) or carotid endarterectomy (CEA) is rare but often fatal once intracranial hemorrhage has occurred. In particular, CHS occurs significantly earlier after CAS than after CEA. Thus a monitoring method for early detection of CHS is required. Near-infrared spectroscopy (NIRS) provides a noninvasive monitoring technique for assessing regional cerebral oxygen saturation (rSO2). This study evaluated the usefulness of transcranial NIRS during CAS for prediction of CHS. Methods: Periprocedural rSO2 was monitored in 64 cases of CAS (52 men, 12 women; 71 ± 6.6 years). The average degree of carotid stenosis was 76.8 ± 11.3% by North American Symptomatic Carotid Endarterectomy Trial criteria. Bifrontal rSO2 was monitored during the procedure using NIRS. Seventeen patients were symptomatic and 47 were asymptomatic. CHS was diagnosed by increased cerebral blood flow by SPECT performed on the day after treatment with deterioration of neurologic symptoms. Results: CHS was observed in two cases (3.1%). In the CHS group, post-reperfusion rSO2 values increased >24% from baseline until 3 minutes after reperfusion. In the non-CHS group, the normal upper limit (NUL) of the rSO2 change was set at 10.0% at 3 minutes after reperfusion. In the CHS group, rSO2 at 3 minutes after reperfusion was markedly higher than the NUL. In patients showing an rSO2 at 3 minutes after reperfusion increased by more than 10.0%, CHS following CAS could be predicted. CONCLUSION: Periprocedural increases in regional cerebral oxygen saturation measured by near- infrared spectroscopy can be an excellent predictor of cerebral hyperperfusion syndrome after carotid artery stenting.

元の言語英語
ページ(範囲)1512-1518
ページ数7
ジャーナルNeurology
72
発行部数17
DOI
出版物ステータス出版済み - 4 28 2009

Fingerprint

Near-Infrared Spectroscopy
Carotid Arteries
Reperfusion
Carotid Endarterectomy
Cerebrovascular Circulation
Oxygen
Intracranial Hemorrhages
Carotid Stenosis
Neurologic Manifestations
Single-Photon Emission-Computed Tomography

All Science Journal Classification (ASJC) codes

  • Clinical Neurology

これを引用

Matsumoto, S., Nakahara, I., Higashi, T., Iwamuro, Y., Watanabe, Y., Takahashi, K., ... Kira, J. I. (2009). Near-infrared spectroscopy in carotid artery stenting predicts cerebral hyperperfusion syndrome. Neurology, 72(17), 1512-1518. https://doi.org/10.1212/WNL.0b013e3181a2e846

Near-infrared spectroscopy in carotid artery stenting predicts cerebral hyperperfusion syndrome. / Matsumoto, S.; Nakahara, I.; Higashi, T.; Iwamuro, Y.; Watanabe, Y.; Takahashi, K.; Ando, M.; Takezawa, M.; Kira, J. I.

:: Neurology, 巻 72, 番号 17, 28.04.2009, p. 1512-1518.

研究成果: ジャーナルへの寄稿記事

Matsumoto, S, Nakahara, I, Higashi, T, Iwamuro, Y, Watanabe, Y, Takahashi, K, Ando, M, Takezawa, M & Kira, JI 2009, 'Near-infrared spectroscopy in carotid artery stenting predicts cerebral hyperperfusion syndrome', Neurology, 巻. 72, 番号 17, pp. 1512-1518. https://doi.org/10.1212/WNL.0b013e3181a2e846
Matsumoto S, Nakahara I, Higashi T, Iwamuro Y, Watanabe Y, Takahashi K その他. Near-infrared spectroscopy in carotid artery stenting predicts cerebral hyperperfusion syndrome. Neurology. 2009 4 28;72(17):1512-1518. https://doi.org/10.1212/WNL.0b013e3181a2e846
Matsumoto, S. ; Nakahara, I. ; Higashi, T. ; Iwamuro, Y. ; Watanabe, Y. ; Takahashi, K. ; Ando, M. ; Takezawa, M. ; Kira, J. I. / Near-infrared spectroscopy in carotid artery stenting predicts cerebral hyperperfusion syndrome. :: Neurology. 2009 ; 巻 72, 番号 17. pp. 1512-1518.
@article{470a2f0470f54996955be2a07c30b09d,
title = "Near-infrared spectroscopy in carotid artery stenting predicts cerebral hyperperfusion syndrome",
abstract = "Objective: Cerebral hyperperfusion syndrome (CHS) following carotid artery stenting (CAS) or carotid endarterectomy (CEA) is rare but often fatal once intracranial hemorrhage has occurred. In particular, CHS occurs significantly earlier after CAS than after CEA. Thus a monitoring method for early detection of CHS is required. Near-infrared spectroscopy (NIRS) provides a noninvasive monitoring technique for assessing regional cerebral oxygen saturation (rSO2). This study evaluated the usefulness of transcranial NIRS during CAS for prediction of CHS. Methods: Periprocedural rSO2 was monitored in 64 cases of CAS (52 men, 12 women; 71 ± 6.6 years). The average degree of carotid stenosis was 76.8 ± 11.3{\%} by North American Symptomatic Carotid Endarterectomy Trial criteria. Bifrontal rSO2 was monitored during the procedure using NIRS. Seventeen patients were symptomatic and 47 were asymptomatic. CHS was diagnosed by increased cerebral blood flow by SPECT performed on the day after treatment with deterioration of neurologic symptoms. Results: CHS was observed in two cases (3.1{\%}). In the CHS group, post-reperfusion rSO2 values increased >24{\%} from baseline until 3 minutes after reperfusion. In the non-CHS group, the normal upper limit (NUL) of the rSO2 change was set at 10.0{\%} at 3 minutes after reperfusion. In the CHS group, rSO2 at 3 minutes after reperfusion was markedly higher than the NUL. In patients showing an rSO2 at 3 minutes after reperfusion increased by more than 10.0{\%}, CHS following CAS could be predicted. CONCLUSION: Periprocedural increases in regional cerebral oxygen saturation measured by near- infrared spectroscopy can be an excellent predictor of cerebral hyperperfusion syndrome after carotid artery stenting.",
author = "S. Matsumoto and I. Nakahara and T. Higashi and Y. Iwamuro and Y. Watanabe and K. Takahashi and M. Ando and M. Takezawa and Kira, {J. I.}",
year = "2009",
month = "4",
day = "28",
doi = "10.1212/WNL.0b013e3181a2e846",
language = "English",
volume = "72",
pages = "1512--1518",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "17",

}

TY - JOUR

T1 - Near-infrared spectroscopy in carotid artery stenting predicts cerebral hyperperfusion syndrome

AU - Matsumoto, S.

AU - Nakahara, I.

AU - Higashi, T.

AU - Iwamuro, Y.

AU - Watanabe, Y.

AU - Takahashi, K.

AU - Ando, M.

AU - Takezawa, M.

AU - Kira, J. I.

PY - 2009/4/28

Y1 - 2009/4/28

N2 - Objective: Cerebral hyperperfusion syndrome (CHS) following carotid artery stenting (CAS) or carotid endarterectomy (CEA) is rare but often fatal once intracranial hemorrhage has occurred. In particular, CHS occurs significantly earlier after CAS than after CEA. Thus a monitoring method for early detection of CHS is required. Near-infrared spectroscopy (NIRS) provides a noninvasive monitoring technique for assessing regional cerebral oxygen saturation (rSO2). This study evaluated the usefulness of transcranial NIRS during CAS for prediction of CHS. Methods: Periprocedural rSO2 was monitored in 64 cases of CAS (52 men, 12 women; 71 ± 6.6 years). The average degree of carotid stenosis was 76.8 ± 11.3% by North American Symptomatic Carotid Endarterectomy Trial criteria. Bifrontal rSO2 was monitored during the procedure using NIRS. Seventeen patients were symptomatic and 47 were asymptomatic. CHS was diagnosed by increased cerebral blood flow by SPECT performed on the day after treatment with deterioration of neurologic symptoms. Results: CHS was observed in two cases (3.1%). In the CHS group, post-reperfusion rSO2 values increased >24% from baseline until 3 minutes after reperfusion. In the non-CHS group, the normal upper limit (NUL) of the rSO2 change was set at 10.0% at 3 minutes after reperfusion. In the CHS group, rSO2 at 3 minutes after reperfusion was markedly higher than the NUL. In patients showing an rSO2 at 3 minutes after reperfusion increased by more than 10.0%, CHS following CAS could be predicted. CONCLUSION: Periprocedural increases in regional cerebral oxygen saturation measured by near- infrared spectroscopy can be an excellent predictor of cerebral hyperperfusion syndrome after carotid artery stenting.

AB - Objective: Cerebral hyperperfusion syndrome (CHS) following carotid artery stenting (CAS) or carotid endarterectomy (CEA) is rare but often fatal once intracranial hemorrhage has occurred. In particular, CHS occurs significantly earlier after CAS than after CEA. Thus a monitoring method for early detection of CHS is required. Near-infrared spectroscopy (NIRS) provides a noninvasive monitoring technique for assessing regional cerebral oxygen saturation (rSO2). This study evaluated the usefulness of transcranial NIRS during CAS for prediction of CHS. Methods: Periprocedural rSO2 was monitored in 64 cases of CAS (52 men, 12 women; 71 ± 6.6 years). The average degree of carotid stenosis was 76.8 ± 11.3% by North American Symptomatic Carotid Endarterectomy Trial criteria. Bifrontal rSO2 was monitored during the procedure using NIRS. Seventeen patients were symptomatic and 47 were asymptomatic. CHS was diagnosed by increased cerebral blood flow by SPECT performed on the day after treatment with deterioration of neurologic symptoms. Results: CHS was observed in two cases (3.1%). In the CHS group, post-reperfusion rSO2 values increased >24% from baseline until 3 minutes after reperfusion. In the non-CHS group, the normal upper limit (NUL) of the rSO2 change was set at 10.0% at 3 minutes after reperfusion. In the CHS group, rSO2 at 3 minutes after reperfusion was markedly higher than the NUL. In patients showing an rSO2 at 3 minutes after reperfusion increased by more than 10.0%, CHS following CAS could be predicted. CONCLUSION: Periprocedural increases in regional cerebral oxygen saturation measured by near- infrared spectroscopy can be an excellent predictor of cerebral hyperperfusion syndrome after carotid artery stenting.

UR - http://www.scopus.com/inward/record.url?scp=67549142841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67549142841&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e3181a2e846

DO - 10.1212/WNL.0b013e3181a2e846

M3 - Article

C2 - 19398706

AN - SCOPUS:67549142841

VL - 72

SP - 1512

EP - 1518

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 17

ER -